Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-Bari semaglutide for patients awaiting bariatric surgery in the Brazilian public health system
RBR-6gjvsy3Phase 4Recruiting
- Sponsor
- Hospital Nossa Senhora da Conceição
- Start
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of semaglutide in obesity and class III obesity (2 arms), sponsored by Hospital Nossa Senhora da Conceição. Started Jun 2026; status: recruiting.
02
Drugs
03
Conditions
obesityclass III obesity
Beyond the preview
Go deeper on RBR-6gjvsy3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6gjvsy3.